Join the Oncology Voice Network. Join for Free
IMPOSTER: Why Do I STINK so much
Imposter syndrome overcoming self-doubt growth mindset managing inadequacy self-awareness strategies

IMPOSTER: Why Do I STINK so much


Share This Article


Summary

In this episode, Tom Caravela delves into the pervasive issue of imposter syndrome, sharing personal insights and experiences. He candidly discusses his own encounters with feelings of inadequacy and how he managed to navigate them. Tom offers practical strategies to combat imposter syndrome, emphasizing the importance of self-awareness and positive reinforcement. He encourages listeners to recognize their achievements and maintain a supportive network. The episode wraps up with Tom's final thoughts, urging the audience to engage with the community and take proactive steps towards overcoming self-doubt.

Tom Caravela, Managing Partner at The Carolan Group and Co-Founder of MSL Mastery, discusses the 5 ways to overcome imposter syndrome

Tom shares….

πŸ‘‰ What is Imposter Syndrome
πŸ‘‰ How can you overcome imposter syndrome
πŸ‘‰ What is comparison-itis
πŸ‘‰ Why should you “touch some grass”
πŸ‘‰ How to develop a growth mindset

Click for Source
Imposter syndrome, overcoming self-doubt, growth mindset, managing inadequacy, self-awareness strategies

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Leverage YOUR Unique Skills for Career Advantage
Partner Avatar MSL Talk: Tom Caravela, Hahn-Ey Lee

How to Leverage YOUR Unique Skills for Career Advantage

Podcast
Business Acumen: The Other MSL Currency
Partner Avatar MSL Talk: Tom Caravela, Maria Abunto, Nabhan Islam

Business Acumen: The Other MSL Currency

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN